1. Bianco AC, Salvatore D, Gereben B, Berry MJ, Larsen PR 2002 Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. Endocr Rev 23:38-89

2. Bianco AC, Kim BW 2006 Deiodinases: implications of the local control of thyroid hormone action. J Clin Invest 116:2571-9

3. Bianco AC, Larsen PR 2005 Intracellular pathways of iodothyronine metabolism. Lippincot Williams & Wilkins, Philadelphia, USA

4. Escobar-Morreale HF, del Rey FE, Obregon MJ, de Escobar GM 1996 Only the combined treatment with thyroxine and triiodothyronine ensures euthyroidism in all tissues of the thyroidectomized rat. Endocrinology 137:2490-502

5. Escobar-Morreale HF, Obregon MJ, Escobar del Rey F, Morreale de Escobar G 1999 Tissue-specific patterns of changes in 3,5,3'-triiodo-L-thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms? Biochimie 81:453-62

6. Bunevicius R, Jakubonien N, Jurkevicius R, Cernicat J, Lasas L, Prange AJ, Jr. 2002 Thyroxine vs thyroxine plus triiodothyronine in treatment of hypothyroidism after thyroidectomy for Graves' disease. Endocrine 18:129-33

7. Escobar-Morreale HF, Botella-Carretero JI, Gomez-Bueno M, Galan JM, Barrios V, Sancho J 2005 Thyroid hormone replacement therapy in primary hypothyroidism: a randomized trial comparing L-thyroxine plus liothyronine with L-thyroxine alone. Ann Intern Med 142:412-24

8. Hennemann G, Docter R, Visser TJ, Postema PT, Krenning EP 2004 Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 14:271-5

9. Visser TJ 1996 Pathways of thyroid hormone metabolism. Acta Med Austriaca 23:10-6

10. Wu SY, Green WL, Huang WS, Hays MT, Chopra IJ 2005 Alternate pathways of thyroid hormone metabolism. Thyroid 15:943-58

11. Visser TJ 1994 Role of sulfation in thyroid hormone metabolism. Chem Biol Interact 92:293-303

12. Scanlan TS, Suchland KL, Hart ME, et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 10:638-42

13. Moreno M, de Lange P, Lombardi A, Silvestri E, Lanni A, Goglia F 2008 Metabolic effects of thyroid hormone derivatives. Thyroid 18:239-53

14. Piehl S, Heberer T, Balizs G, et al. 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 149:3037-45

15. Baqui MM, Gereben B, Harney JW, Larsen PR, Bianco AC 2000 Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141:4309-12

16. Toyoda N, Berry MJ, Harney JW, Larsen PR 1995 Topological analysis of the integral membrane protein, type 1 iodothyronine deiodinase (D1). J Biol Chem 270:12310-8

17. Bianco AC, Larsen PR 2005 Cellular and structural biology of the deiodinases. Thyroid 15:777-86

18. Curcio-Morelli C, Gereben B, Zavacki AM, et al. 2003 In vivo dimerization of types 1, 2, and 3 iodothyronine selenodeiodinases. Endocrinology 144:937-46

19. Leonard JL, Simpson G, Leonard DM 2005 Characterization of the protein dimerization domain responsible for assembly of functional selenodeiodinases. J Biol Chem 280:11093-100

20. Leonard JL, Visser TJ, Leonard DM 2001 Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase. J Biol Chem 276:2600-7

21. Hoffmann PR, Berry MJ 2005 Selenoprotein synthesis: a unique translational mechanism used by a diverse family of proteins. Thyroid 15:769-75

22. Beckett GJ, Beddows SE, Morrice PC, Nicol F, Arthur JR 1987 Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. Biochem J 248:443-7

23. Berry MJ, Maia AL, Kieffer JD, Harney JW, Larsen PR 1992 Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Endocrinology 131:1848-52

24. Berry MJ, Kieffer JD, Harney JW, Larsen PR 1991 Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. J Biol Chem 266:14155-8

25. Sanders JP, Van der Geyten S, Kaptein E, et al. 1997 Characterization of a propylthiouracil-insensitive type I iodothyronine deiodinase. Endocrinology 138:5153-60

26. Kuiper GG, Klootwijk W, Morvan Dubois G, et al. 2006 Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil. Endocrinology 147:3519-29

27. Callebaut I, Curcio-Morelli C, Mornon JP, et al. 2003 The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. J Biol Chem 278:36887-96

28. O'Mara BA, Dittrich W, Lauterio TJ, St Germain DL 1993 Pretranslational regulation of type I 5'-deiodinase by thyroid hormones and in fasted and diabetic rats. Endocrinology 133:1715-23

29. Toyoda N, Zavacki AM, Maia AL, Harney JW, Larsen PR 1995 A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Mol Cell Biol 15:5100-12

30. Jakobs TC, Schmutzler C, Meissner J, Kohrle J 1997 The promoter of the human type I 5'-deiodinase gene--mapping of the transcription start site and identification of a DR+4 thyroid-hormone-responsive element. Eur J Biochem 247:288-97

31. Amma LL, Campos-Barros A, Wang Z, Vennstrom B, Forrest D 2001 Distinct tissue-specific roles for thyroid hormone receptors beta and alpha1 in regulation of type 1 deiodinase expression. Mol Endocrinol 15:467-75

32. Zandieh Doulabi B, Platvoet-ter Schiphorst M, van Beeren HC, et al. 2002 TR(beta)1 protein is preferentially expressed in the pericentral zone of rat liver and exhibits marked diurnal variation. Endocrinology 143:979-84

33. Toyoda N, Nishikawa M, Horimoto M, et al. 1990 Synergistic effect of thyroid hormone and thyrotropin on iodothyronine 5'-deiodinase in FRTL-5 rat thyroid cells. Endocrinology 127:1199-205

34. Toyoda N, Nishikawa M, Horimoto M, et al. 1990 Graves' immunoglobulin G stimulates iodothyronine 5'-deiodinating activity in FRTL-5 rat thyroid cells. J Clin Endocrinol Metab 70:1506-11

35. Beckett GJ, MacDougall DA, Nicol F, Arthur R 1989 Inhibition of type I and type II iodothyronine deiodinase activity in rat liver, kidney and brain produced by selenium deficiency. Biochem J 259:887-92

36. Chanoine JP, Safran M, Farwell AP, et al. 1992 Effects of selenium deficiency on thyroid hormone economy in rats. Endocrinology 131:1787-92

37. Berry MJ, Grieco D, Taylor BA, et al. 1993 Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5' deiodinase deficiency. J Clin Invest 92:1517-28

38. Schoenmakers CH, Pigmans IG, Poland A, Visser TJ 1993 Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. Endocrinology 132:357-61

39. Maia AL, Berry MJ, Sabbag R, Harney JW, Larsen PR 1995 Structural and functional differences in the dio1 gene in mice with inherited type 1 deiodinase deficiency. Mol Endocrinol 9:969-80

40. Streckfuss F, Hamann I, Schomburg L, et al. 2005 Hepatic deiodinase activity is dispensable for the maintenance of normal circulating thyroid hormone levels in mice. Biochem Biophys Res Commun 337:739-45

41. Schneider MJ, Fiering SN, Thai B, et al. 2006 Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid hormone economy in mice. Endocrinology 147:580-9

42. Zavacki AM, Ying H, Christoffolete MA, et al. 2005 Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. Endocrinology 146:1568-75

43. Panicker V, Cluett C, Shields B, et al. 2008 A Common variation in Deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triidothyronine. J Clin Endocrinol Metab

44. Peeters RP, van der Deure WM, Visser TJ 2006 Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. Eur J Endocrinol 155:655-62

45. de Jong FJ, Peeters RP, den Heijer T, et al. 2007 The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. J Clin Endocrinol Metab 92:636-40

46. Salvatore D, Tu H, Harney JW, Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. J Clin Invest 98:962-8

47. Imai Y, Toyoda N, Maeda A, et al. 2001 Type 2 iodothyronine deiodinase expression is upregulated by the protein kinase A-dependent pathway and is downregulated by the protein kinase C-dependent pathway in cultured human thyroid cells. Thyroid 11:899-907

48. Murakami M, Araki O, Hosoi Y, et al. 2001 Expression and regulation of type II iodothyronine deiodinase in human thyroid gland. Endocrinology 142:2961-7

49. Hosoi Y, Murakami M, Mizuma H, Ogiwara T, Imamura M, Mori M 1999 Expression and regulation of type II iodothyronine deiodinase in cultured human skeletal muscle cells. J Clin Endocrinol Metab 84:3293-300

50. Dentice M, Morisco C, Vitale M, Rossi G, Fenzi G, Salvatore D 2003 The different cardiac expression of the type 2 iodothyronine deiodinase gene between human and rat is related to the differential response of the Dio2 genes to Nkx-2.5 and GATA-4 transcription factors. Mol Endocrinol 17:1508-21

51. Guadano-Ferraz A, Obregon MJ, St Germain DL, Bernal J 1997 The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain. Proc Natl Acad Sci U S A 94:10391-6

52. Courtin F, Liva P, Gavaret JM, Toru-Delbauffe D, Pierre M 1991 Induction of 5-deiodinase activity in astroglial cells by 12-O-tetradecanoylphorbol 13-acetate and fibroblast growth factors. J Neurochem 56:1107-13

53. Lamirand A, Mercier G, Ramauge M, Pierre M, Courtin F 2007 Hypoxia stabilizes type 2 deiodinase activity in rat astrocytes. Endocrinology 148:4745-53

54. Leonard JL 1988 Dibutyryl cAMP induction of type II 5'deiodinase activity in rat brain astrocytes in culture. Biochem Biophys Res Commun 151:1164-72

55. Simpson GI, Leonard DM, Leonard JL 2006 Identification of the key residues responsible for the assembly of selenodeiodinases. J Biol Chem 281:14615-21

56. Curcio-Morelli C, Zavacki AM, Christofollete M, et al. 2003 Deubiquitination of type 2 iodothyronine deiodinase by von Hippel-Lindau protein-interacting deubiquitinating enzymes regulates thyroid hormone activation. J Clin Invest 112:189-96

57. Dentice M, Bandyopadhyay A, Gereben B, et al. 2005 The Hedgehog-inducible ubiquitin ligase subunit WSB-1 modulates thyroid hormone activation and PTHrP secretion in the developing growth plate. Nat Cell Biol 7:698-705

58. Kim BW, Zavacki AM, Curcio-Morelli C, et al. 2003 Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2. Mol Endocrinol 17:2603-12

59. Sagar GD, Gereben B, Callebaut I, et al. 2007 Ubiquitination-induced conformational change within the deiodinase dimer is a switch regulating enzyme activity. Mol Cell Biol 27:4774-83

60. Halperin Y, Shapiro LE, Surks MI 1994 Down-regulation of type II L-thyroxine, 5'-monodeiodinase in cultured GC cells: different pathways of regulation by L-triiodothyronine and 3,3',5'-triiodo-L-thyronine. Endocrinology 135:1464-9

61. Burmeister LA, Pachucki J, St Germain DL 1997 Thyroid hormones inhibit type 2 iodothyronine deiodinase in the rat cerebral cortex by both pre- and posttranslational mechanisms. Endocrinology 138:5231-7

62. Kim SW, Harney JW, Larsen PR 1998 Studies of the hormonal regulation of type 2 5'-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139:4895-905

63. Buettner C, Harney JW, Larsen PR 2000 The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Endocrinology 141:4606-12

64. Kuiper GG, Klootwijk W, Visser TJ 2002 Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor. Endocrinology 143:1190-8

65. Steinsapir J, Bianco AC, Buettner C, Harney J, Larsen PR 2000 Substrate-induced down-regulation of human type 2 deiodinase (hD2) is mediated through proteasomal degradation and requires interaction with the enzyme's active center. Endocrinology 141:1127-35

66. Salvatore D, Harney JW, Larsen PR 1999 Mutation of the Secys residue 266 in human type 2 selenodeiodinase alters 75Se incorporation without affecting its biochemical properties. Biochimie 81:535-8

67. Gereben B, Kollar A, Harney JW, Larsen PR 2002 The mRNA structure has potent regulatory effects on type 2 iodothyronine deiodinase expression. Mol Endocrinol 16:1667-79

68. Gereben B, Salvatore D, Harney JW, Tu HM, Larsen PR 2001 The human, but not rat, dio2 gene is stimulated by thyroid transcription factor-1 (TTF-1). Mol Endocrinol 15:112-24

69. Bartha T, Kim SW, Salvatore D, et al. 2000 Characterization of the 5'-flanking and 5'-untranslated regions of the cyclic adenosine 3',5'-monophosphate-responsive human type 2 iodothyronine deiodinase gene. Endocrinology 141:229-37

70. Canettieri G, Celi FS, Baccheschi G, Salvatori L, Andreoli M, Centanni M 2000 Isolation of human type 2 deiodinase gene promoter and characterization of a functional cyclic adenosine monophosphate response element. Endocrinology 141:1804-13

71. Kim BW, Daniels GH, Harrison BJ, et al. 2003 Overexpression of type 2 iodothyronine deiodinase in follicular carcinoma as a cause of low circulating free thyroxine levels. J Clin Endocrinol Metab 88:594-8

72. Miyauchi A, Takamura Y, Ito Y, et al. 2008 3,5,3'-Triiodothyronine thyrotoxicosis due to increased conversion of administered levothyroxine in patients with massive metastatic follicular thyroid carcinoma. J Clin Endocrinol Metab 93:2239-42

73. Takano T, Miyauchi A, Ito Y, Amino N 2006 Thyroxine to triiodothyronine hyperconversion thyrotoxicosis in patients with large metastases of follicular thyroid carcinoma. Thyroid 16:615-8

74. Schneider MJ, Fiering SN, Pallud SE, Parlow AF, St Germain DL, Galton VA 2001 Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Mol Endocrinol 15:2137-48

75. de Jesus LA, Carvalho SD, Ribeiro MO, et al. 2001 The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest 108:1379-85

76. Ng L, Goodyear RJ, Woods CA, et al. 2004 Hearing loss and retarded cochlear development in mice lacking type 2 iodothyronine deiodinase. Proc Natl Acad Sci U S A 101:3474-9

77. Dumitrescu AM, Liao XH, Abdullah MS, et al. 2005 Mutations in SECISBP2 result in abnormal thyroid hormone metabolism. Nat Genet 37:1247-52

78. Canani LH, Capp C, Dora JM, et al. 2005 The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. J Clin Endocrinol Metab 90:3472-8

79. Peeters RP, van den Beld AW, Attalki H, et al. 2005 A new polymorphism in the type II deiodinase gene is associated with circulating thyroid hormone parameters. Am J Physiol Endocrinol Metab 289:E75-81

80. Peeters RP, van Toor H, Klootwijk W, et al. 2003 Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. J Clin Endocrinol Metab 88:2880-8

81. Grarup N, Andersen MK, Andreasen CH, et al. 2007 Studies of the common DIO2 Thr92Ala polymorphism and metabolic phenotypes in 7342 Danish white subjects. J Clin Endocrinol Metab 92:363-6

82. Bates JM, St Germain DL, Galton VA 1999 Expression profiles of the three iodothyronine deiodinases, D1, D2, and D3, in the developing rat. Endocrinology 140:844-51

83. Galton VA, Martinez E, Hernandez A, St Germain EA, Bates JM, St Germain DL 1999 Pregnant rat uterus expresses high levels of the type 3 iodothyronine deiodinase. J Clin Invest 103:979-87

84. Santini F, Vitti P, Chiovato L, et al. 2003 Role for inner ring deiodination preventing transcutaneous passage of thyroxine. J Clin Endocrinol Metab 88:2825-30

85. Dentice M, Luongo C, Huang S, et al. 2007 Sonic hedgehog-induced type 3 deiodinase blocks thyroid hormone action enhancing proliferation of normal and malignant keratinocytes. Proc Natl Acad Sci U S A 104:14466-71

86. Sato K, Robbins J 1980 Thyroid hormone metabolism in cultured monkey hepatocarcinoma cells. Monodeiodination activity in relation to cell growth. J Biol Chem 255:7347-52

87. Huang SA, Tu HM, Harney JW, et al. 2000 Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 343:185-9

88. Baqui M, Botero D, Gereben B, et al. 2003 Human type 3 iodothyronine selenodeiodinase is located in the plasma membrane and undergoes rapid internalization to endosomes. J Biol Chem 278:1206-11

89. Sagar GD, Gereben B, Callebaut I, et al. 2008 The thyroid hormone-inactivating deiodinase functions as a homodimer. Mol Endocrinol 22:1382-93

90. Tu HM, Legradi G, Bartha T, Salvatore D, Lechan RM, Larsen PR 1999 Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140:784-90

91. Huang SA, Bianco AC 2008 Reawakened interest in type III iodothyronine deiodinase in critical illness and injury. Nat Clin Pract Endocrinol Metab 4:148-55

92. Santini F, Pinchera A, Ceccarini G, et al. 2001 Evidence for a role of the type III-iodothyronine deiodinase in the regulation of 3,5,3'-triiodothyronine content in the human central nervous system. Eur J Endocrinol 144:577-83

93. Kester MH, Martinez de Mena R, Obregon MJ, et al. 2004 Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. J Clin Endocrinol Metab 89:3117-28

94. Huang SA, Fish SA, Dorfman DM, et al. 2002 A 21-year-old woman with consumptive hypothyroidism due to a vascular tumor expressing type 3 iodothyronine deiodinase. J Clin Endocrinol Metab 87:4457-61

95. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ, Van den Berghe G 2003 Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. J Clin Endocrinol Metab 88:3202-11

96. Wassen FW, Schiel AE, Kuiper GG, et al. 2002 Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure. Endocrinology 143:2812-5

97. Olivares EL, Marassi MP, Fortunato RS, et al. 2007 Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148:4786-92

98. Simonides WS, Mulcahey MA, Redout EM, et al. 2008 Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118:975-83

99. Boelen A, Kwakkel J, Alkemade A, et al. 2005 Induction of type 3 deiodinase activity in inflammatory cells of mice with chronic local inflammation. Endocrinology 146:5128-34

100. Hernandez A, Fiering S, Martinez E, Galton VA, St Germain D 2002 The gene locus encoding iodothyronine deiodinase type 3 (Dio3) is imprinted in the fetus and expresses antisense transcripts. Endocrinology 143:4483-6

101. Hernandez A, Martinez ME, Fiering S, Galton VA, St Germain D 2006 Type 3 deiodinase is critical for the maturation and function of the thyroid axis. J Clin Invest 116:476-84

102. Hernandez A, Martinez ME, Liao XH, et al. 2007 Type 3 deiodinase deficiency results in functional abnormalities at multiple levels of the thyroid axis. Endocrinology 148:5680-7

103. Kempers MJ, van Tijn DA, van Trotsenburg AS, de Vijlder JJ, Wiedijk BM, Vulsma T 2003 Central congenital hypothyroidism due to gestational hyperthyroidism: detection where prevention failed. J Clin Endocrinol Metab 88:5851-7

104. Bermano G, Nicol F, Dyer JA, et al. 1995 Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochem J 311 ( Pt 2):425-30

105. Berry MJ 2005 Insights into the hierarchy of selenium incorporation. Nat Genet 37:1162-3

106. Van der Geyten S, Buys N, Sanders JP, et al. 1999 Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos. Mol Cell Endocrinol 147:49-56

107. Van der Geyten S, Sanders JP, Kaptein E, et al. 1997 Expression of chicken hepatic type I and type III iodothyronine deiodinases during embryonic development. Endocrinology 138:5144-52

108. Richard K, Hume R, Kaptein E, et al. 1998 Ontogeny of iodothyronine deiodinases in human liver. J Clin Endocrinol Metab 83:2868-74

109. Roti E, Gnudi A, Braverman LE 1983 The placental transport, synthesis and metabolism of hormones and drugs which affect thyroid function. Endocr Rev 4:131-49

110. Koopdonk-Kool JM, de Vijlder JJ, Veenboer GJ, et al. 1996 Type II and type III deiodinase activity in human placenta as a function of gestational age. J Clin Endocrinol Metab 81:2154-8

111. Pacifici GM, Coughtrie MW 2005 Human Cytosolic Sulfotransferases. Taylor & Francis, Baco Raton

112. Blanchard RL, Freimuth RR, Buck J, Weinshilboum RM, Coughtrie MW 2004 A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 14:199-211

113. Fujita K, Nagata K, Ozawa S, Sasano H, Yamazoe Y 1997 Molecular cloning and characterization of rat ST1B1 and human ST1B2 cDNAs, encoding thyroid hormone sulfotransferases. J Biochem 122:1052-61

114. Kester MH, Kaptein E, Roest TJ, et al. 1999 Characterization of human iodothyronine sulfotransferases. J Clin Endocrinol Metab 84:1357-64

115. Kester MH, van Dijk CH, Tibboel D, et al. 1999 Sulfation of thyroid hormone by estrogen sulfotransferase. J Clin Endocrinol Metab 84:2577-80

116. Li X, Anderson RJ 1999 Sulfation of iodothyronines by recombinant human liver steroid sulfotransferases. Biochem Biophys Res Commun 263:632-9

117. Li X, Clemens DL, Anderson RJ 2000 Sulfation of iodothyronines by human sulfotransferase 1C1 (SULT1C1)*. Biochem Pharmacol 60:1713-6

118. Pietsch CA, Scanlan TS, Anderson RJ 2007 Thyronamines are substrates for human liver sulfotransferases. Endocrinology 148:1921-7

119. Visser TJ, Kaptein E, Glatt H, Bartsch I, Hagen M, Coughtrie MW 1998 Characterization of thyroid hormone sulfotransferases. Chem Biol Interact 109:279-91

120. Wang J, Falany JL, Falany CN 1998 Expression and characterization of a novel thyroid hormone-sulfating form of cytosolic sulfotransferase from human liver. Mol Pharmacol 53:274-82

121. Venkatachalam KV, Akita H, Strott CA 1998 Molecular cloning, expression, and characterization of human bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase and its functional domains. J Biol Chem 273:19311-20

122. Eelkman Rooda SJ, Kaptein E, Visser TJ 1989 Serum triiodothyronine sulfate in man measured by radioimmunoassay. J Clin Endocrinol Metab 69:552-6

123. Chopra MFI 1996 Nonthyroidal illness syndrome or euthyroid sick syndrome? Endocr Pract 2:45-52

124. Kester MH, Kaptein E, Van Dijk CH, et al. 2002 Characterization of iodothyronine sulfatase activities in human and rat liver and placenta. Endocrinology 143:814-9

125. Santini F, Chopra IJ, Wu SY, Solomon DH, Chua Teco GN 1992 Metabolism of 3,5,3'-triiodothyronine sulfate by tissues of the fetal rat: a consideration of the role of desulfation of 3,5,3'-triiodothyronine sulfate as a source of T3. Pediatr Res 31:541-4

126. Wu SY, Huang WS, Ho E, Wu ES, Fisher DA 2007 Compound W, a 3,3'-diiodothyronine sulfate cross-reactive substance in serum from pregnant women--a potential marker for fetal thyroid function. Pediatr Res 61:307-12

127. Mackenzie PI, Bock KW, Burchell B, et al. 2005 Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 15:677-85

128. Hennemann G, Visser TJ 1997 Thyroid hormone synthesis, plasma membrane transport, and metabolism.

129. Brouwer A, Morse DC, Lans MC, et al. 1998 Interactions of persistent environmental organohalogens with the thyroid hormone system: mechanisms and possible consequences for animal and human health. Toxicol Ind Health 14:59-84

130. Klaassen CD, Hood AM 2001 Effects of microsomal enzyme inducers on thyroid follicular cell proliferation and thyroid hormone metabolism. Toxicol Pathol 29:34-40

131. Visser TJ, Kaptein E, van Toor H, et al. 1993 Glucuronidation of thyroid hormone in rat liver: effects of in vivo treatment with microsomal enzyme inducers and in vitro assay conditions. Endocrinology 133:2177-86

132. Benedetti MS, Whomsley R, Baltes E, Tonner F 2005 Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction. Eur J Clin Pharmacol 61:863-72

133. Kato Y, Ikushiro S, Emi Y, et al. 2008 Hepatic UDP-glucuronosyltransferases responsible for glucuronidation of thyroxine in humans. Drug Metab Dispos 36:51-5

134. Tong Z, Li H, Goljer I, McConnell O, Chandrasekaran A 2007 In vitro glucuronidation of thyroxine and triiodothyronine by liver microsomes and recombinant human UDP-glucuronosyltransferases. Drug Metab Dispos 35:2203-10

135. Yamanaka H, Nakajima M, Katoh M, Yokoi T 2007 Glucuronidation of thyroxine in human liver, jejunum, and kidney microsomes. Drug Metab Dispos 35:1642-8

136. Yoder Graber AL, Ramirez J, Innocenti F, Ratain MJ 2007 UGT1A1*28 genotype affects the in-vitro glucuronidation of thyroxine in human livers. Pharmacogenet Genomics 17:619-27

137. Moreno M, Kaptein E, Goglia F, Visser TJ 1994 Rapid glucuronidation of tri- and tetraiodothyroacetic acid to ester glucuronides in human liver and to ether glucuronides in rat liver. Endocrinology 135:1004-9

138. Bernal J 2005 Thyroid hormones and brain development. Vitam Horm 71:95-122

139. Heuer H, Maier MK, Iden S, et al. 2005 The monocarboxylate transporter 8 linked to human psychomotor retardation is highly expressed in thyroid hormone-sensitive neuron populations. Endocrinology 146:1701-6

140. Maia AL, Kim BW, Huang SA, Harney JW, Larsen PR 2005 Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. J Clin Invest 115:2524-33

141. Laurberg P, Vestergaard H, Nielsen S, et al. 2007 Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. J Clin Endocrinol Metab 92:2149-56